Active Monitoring of the Comparative Effectiveness and Safety of Prasugrel vs. Clopidogrel in Routine Care

被引：0
|
作者：
Gagne, Joshua J. [1 ,2 ]
Rassen, Jeremy A. [1 ,2 ]
Choudhry, Niteesh K. [1 ,2 ]
Bohn, Rhonda L. [3 ]
Patrick, Amanda R. [1 ,2 ]
Sridhar, Gayathri [4 ]
Liu, Jun [1 ,2 ]
Schneeweiss, Sebastian [1 ,2 ]
机构：
[1] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Rhonda L Bohn LLC, Waban, MA USA
[4] HealthCore Inc, Govt & Acad Res, Wilmington, DE USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2012年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
508
引用
收藏
页码：238 / 239
页数：2
相关论文
共 50 条
  • [31] Cost-Effectiveness of Prasugrel vs. Clopidogrel in PCI Patients with Acute Coronary Syndromes: Results from the TRITON-TIMI 38 Economic Study
    Cohen, David J.
    Wang, Kaijun
    Wiviott, Stephen
    Arnold, Suzanne V.
    Antman, Elliott
    Braunwald, Eugene
    Mahoney, Elizabeth M.
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (6A): : XVII - XVII
  • [32] Effectiveness and Safety of Clopidogrel vs Aspirin in Elderly Patients With Ischemic Stroke
    Huang, Hsin-Yi
    Lin, Shin-Yi
    Katz, Aaron J.
    Sheu, Jau-Jiuan
    Lin, Fang-Ju
    Wang, Chi-Chuan
    Wu, Chung-Hsuen
    MAYO CLINIC PROCEEDINGS, 2022, 97 (08) : 1483 - 1492
  • [33] Comparative Effectiveness of Prasugrel vs. Clopidogrel Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: 30-Day Outcomes from the TRANSLATE-ACS Observational Study
    Wang, Tracy Y.
    Zettler, Marjorie
    Effron, Mark B.
    McCoy, Lisa
    Anstrom, Kevin
    Fonarow, Gregg C.
    Messenger, John C.
    Stone, Gregg
    Cohen, David
    Henry, Timothy D.
    Peterson, Eric
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B1 - B1
  • [34] BALANCING EFFICACY AND SAFETY OF PRASUGREL VS. CLOPIDOGREL IN ACUTE CORONARY SYNDROME PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A POPULATION ANALYSIS OF NET CLINICAL BENEFIT
    Schmitt, C.
    McCollam, P. L.
    Creveling, T. L.
    Oberdiek, A.
    VALUE IN HEALTH, 2009, 12 (07) : A317 - A317
  • [35] Real World Effectiveness and Safety of Ticagrelor and Prasugrel as Compared With Clopidogrel Are Inconsistent With the Findings From Clinical Trials
    Yuan, Zhong
    Plotnikov, Alexei N.
    Weaver, James
    Londhe, Ajit
    Barnathan, Elliot
    Strony, John
    CIRCULATION, 2017, 136
  • [36] Low-Dose Prasugrel vs. Standard-Dose Clopidogrel for Patients Undergoing Percutaneous Coronary Intervention
    Kuno, Toshiki
    Miyamoto, Yoshihisa
    Akita, Keitaro
    Shoji, Satoshi
    Numasawa, Yohei
    Ueda, Ikuko
    Noma, Shigetaka
    Fukuda, Keiichi
    Kohsaka, Shun
    CIRCULATION JOURNAL, 2024, 88 (11) : 1745 - 1753
  • [37] Prasugrel vs. clopidogrel in contemporary Western European patients with acute coronary syndromes receiving drug-eluting stents: Comparative cost-effectiveness analysis from the BASKET-PROVE cohorts
    Wein, Bastian
    Coslovsky, Michael
    Jabbari, Reza
    Galatius, Soren
    Pfisterer, Matthias
    Kaiser, Christoph
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 248 : 20 - 27
  • [38] Rivaroxaban versus warfarin and dabigatran in atrial fibrillation: comparative effectiveness and safety in Danish routine care
    Gorst-Rasmussen, Anders
    Lip, Gregory Y. H.
    Larsen, Torben Bjerregaard
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 (11) : 1236 - 1244
  • [39] Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction
    Schulz, Stefanie
    Richardt, Gert
    Laugwitz, Karl-Ludwig
    Morath, Tanja
    Neudecker, Julia
    Hoppmann, Petra
    Mehran, Roxana
    Gershlick, Anthony H.
    Toelg, Ralph
    Fiedler, K. Anette
    Abdel-Wahab, Mohamed
    Kufner, Sebastian
    Schneider, Simon
    Schunkert, Heribert
    Ibrahim, Tareq
    Mehilli, Julinda
    Kastrati, Adnan
    EUROPEAN HEART JOURNAL, 2014, 35 (34) : 2285 - +
  • [40] Comparison of prasugrel vs. high clopidogrel maintenance dose to overcome high residual platelet reactivity post stenting
    Xanthopoulou, I.
    Dimitropoulos, G.
    Kasimis, G.
    Stavrou, E.
    Panagiotou, A.
    Tsigkas, G.
    Davlouros, P.
    Hahalis, G.
    Athanassiadou, A.
    Alexopoulos, D.
    EUROPEAN HEART JOURNAL, 2010, 31 : 173 - 173
12345